Results from a Single Institution Phase II Trial of Concurrent Docetaxel/Carboplatin/Radiotherapy Followed by Surgical Resection and Consolidation Docetaxel/Carboplatin in Stage III Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Results from a Single Institution Phase II Trial of Concurrent Docetaxel/Carboplatin/Radiotherapy Followed by Surgical Resection and Consolidation Docetaxel/Carboplatin in Stage III Non–Small-Cell Lung Cancer

Published:2011-09 Issue:5 Volume:12 Page:280-285
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Das Millie,Donington Jessica S.,Murphy James,Kozak Margaret,Eclov Neville,Whyte Richard I.,Hoang Chuong D.,Zhou Lisa,Le Quynh-Thu,Loo Billy W.,Wakelee Heather

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference17 articles.

1. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease;Keller;J Thorac Cardiovasc Surg,2004

2. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

3. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805;Albain;J Clin Oncol,1995

4. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504;Gandara;J Clin Oncol,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positive therapy outcome of lung squamous cell cancer: A case report;Experimental and Therapeutic Medicine;2022-05-09

2. Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer;Journal of Thoracic Oncology;2011-05